Asking questions about screening inequalities

Survey results will hopefully help focus future screening inequalities research where it is needed most.
Survey results will hopefully help focus future screening inequalities research where it is needed most.
Dr Jessica Lloyd and Dr Sowmiya Moorthie, of Cancer Research UK, discuss multi-cancer tests, their potential use in screening, their challenges and uncertainties.
How much do you know about the UK National Screening Committee?
Screening identifies apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment or informed decisions. National population screening programmes are implemented on the advice of the UK National Screening Committee (UK NSC), which makes independent, evidence-based recommendations to …
An article to get you thinking about screening, and its balance of risks and benefits.
More than 200 stakeholders attended a fascinating UK National Screening Committee (UK NSC) seminar exploring multi-cancer detection tests (MCDs) and their potential use in a screening context. Attendees included academics, clinicians, researchers, industry representatives, patient organisations, screening providers, policy makers …
Please complete short survey to help us improve the way the UK NSC involves stakeholders and the public in its work.
Find out more about the role local government public health teams play in screening.
Cancer Research UK Strategic Evidence Manager Hope Walters talks about her experience of attending the Health Screening Module at the University of Warwick.
Experts discussed the potential role and challenges of surrogate endpoints in cancer screening in a webinar hosted by Cancer Research UK and Consilium Scientific.